Correlation Between GlaxoSmithKline PLC and BM Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and BM Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and BM Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and BM Technologies WT, you can compare the effects of market volatilities on GlaxoSmithKline PLC and BM Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of BM Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and BM Technologies.

Diversification Opportunities for GlaxoSmithKline PLC and BM Technologies

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and BMTX-WT is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and BM Technologies WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BM Technologies WT and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with BM Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BM Technologies WT has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and BM Technologies go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and BM Technologies

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.31 times more return on investment than BM Technologies. However, GlaxoSmithKline PLC ADR is 3.24 times less risky than BM Technologies. It trades about -0.3 of its potential returns per unit of risk. BM Technologies WT is currently generating about -0.1 per unit of risk. If you would invest  3,774  in GlaxoSmithKline PLC ADR on August 30, 2024 and sell it today you would lose (341.00) from holding GlaxoSmithKline PLC ADR or give up 9.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  BM Technologies WT

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
BM Technologies WT 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BM Technologies WT are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, BM Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and BM Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and BM Technologies

The main advantage of trading using opposite GlaxoSmithKline PLC and BM Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, BM Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BM Technologies will offset losses from the drop in BM Technologies' long position.
The idea behind GlaxoSmithKline PLC ADR and BM Technologies WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes